A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: Gene-environmental interactions behind vascular white matter demyelinization

Journal of Molecular Neuroscience

Volumn 33, Issue 2, 2007, Pages 173-179

  Szolnoki, Zoltan ^a,c   Kondacs, Andras ^a   Mandi, Yvette ^b   Somogyvari, Ferenc ^b  

^a Pandy Kalman Bekes County Hospital   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c NONE   (Hungary)

Author keywords

Cytoskeleton; Genetic variants; Kinesin; Leukoaraiosis; White matter damage

Indexed keywords

KINESIN; KINESIN LIGHT CHAIN 1; MOLECULAR MOTOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL PRACTICE; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOSKELETON; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLIA CELL; HEREDITY; HETEROZYGOTE; HUMAN; HYPERTENSION; HYPOTHESIS; HYPOXIA; INTRON; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; NERVE DEGENERATION; NEUROIMAGING; PROTEIN FUNCTION; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; WHITE MATTER;

AGED; AGED, 80 AND OVER; CYTOSKELETON; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; KINESIN; LEUKOARAIOSIS; MALE; MIDDLE AGED; MODELS, THEORETICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 35348826108     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-007-0062-z     Document Type: Article

References (40)

1. Abe, K., Aoki, M., Kawagoe, J., Yoshida, T., Hattori, A., Kogure, K., et al. (1995). Ischemic delayed neuronal death. A mitochondrial hypothesis. Stroke, 26, 1478-1489.
2. Amar, K., Macgowan, S., Wilcock, G., Lewis, T., & Scott, M. (1998). Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population. International Journal of Geriatric Psychiatry, 13, 585-590.
3. Basile, A. M., Pantoni, L., Pracucci, G., Asplund, K., Chabriat, H., Erkinjuntti, T., et al. (2006). Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovascular Diseases, 2, 315-322.
4. Brown, W. R., Moody, D. M., Thore, C. R., Challa, V. R., & Anstrom, J. A. (2007) Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. Journal of the Neurological Sciences, 257, 62-66.
5. Carson, J. H., Worboys, K., Ainger, K., & Barbarese, E. (1997). Translocation of myelin basic protein mRNA in oligodendrocytes requires microtubulus and kinesin. Cell Motil Cytoskel, 38, 318-328.
6. Dhaenens, C. M., Van Brussel, E., Schraen-Maschke, S., Pasquier, F., Delacourte, A., & Sablonniere B. (2004). Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neuroscience Letters, 368, 290-292.
7. Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I., Zimmerman, R. A. et al. (1987). MRI signal abnormalities at 1.5 T in Alzeimer's dementia and normal aging. American Journal of Roentgenology, 149, 351-356.
8. Fornage, M., Mosley, T. H., Jack, C. R., Andrade, M., Kardia, S., Boerwinkle, E., et al. (2007). Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury. Human Genetics, 120, 671-680.
9. Gould, R. M., Freund, C. M., & Barbarese, E. (1999). Myelin-associated oligodendrocytic basic protein mRNAs reside at different subcellular locations. Journal of Neurochemistry, 73, 1913-1924.
10. Hachinski, V. C., Potter P., & Merskey, H. (1986). Leuko-araiosis: an ancient term for a new problem. Canadian Journal of Neurological Sciences, 13, 533-534.
11. Hassan, A., Hunt, B. J., O'Sullivan, M., Parmar, K., Bamford, J. M., Briley, D., et al. (2003). Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain, 126, 424-432.
12. Inzitari, D., Simoni, M., Pracucci, G., Poggesi, A., Basile, A. M., Chabriat, H., et al. (2007). Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Archives of Internal Medicine, 167, 81-88.
13. Junque, C., Pujol, J., Vendrell, P., Bruna, O., Jodar, M., Ribas, J. C., et al. (1990). Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Archives of Neurology, 47, 151-156.
14. Khan, U., Porteous, L., Hassan, A., & Markus, H. (2007). Risk factor profile of cerebral small vessel disease and its subtypes. Journal of Neurology, Neurosurgery and Psychiatry, 78, 702-706.
15. Liu, C. K., Miller, B. L., Cummings, J. L., Mehringer, C. M., Goldberg, M. A., Howng, S. L., et al. (1992). A quantitative MRI study of vascular dementia. Neurology, 42, 138-143.
16. Markus, H. S., Lythgoe, D. J., Ostegaard, L., O'Sullivan, M., & Williams, S. C. R. (2000). Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. Journal of Neurology, Neurosurgery and Psychiatry, 69, 48-53.
17. Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215-1218.
18. Moody, D. M., Bell, M. A., & Chala, V. R. (1995). Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. American Journal of Neuroradiology, 11, 431-439.
19. Moody, D. M., Thore, C. R., Anstrom, J. A., Challa, V. R., Langefeld, C. D., & Brown, W. R. (2004). Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. Radiology, 223, 883-890.
20. Pantelidou, M., Zographos, S. E., Lederer, C. W., Kyriakides, T., Pfaffl, M. W., & Santama, N. (2007). Differential expression of molecular motors in the motor cortex of sporadic ALS. Neurobiology of Disease, 26, 577-589.
21. Pantoni, L. (2002). Pathophysiology of age-related cerebral white matter changes. Cerebrovascular Diseases, 13(suppl. 2), 7-14.
22. Pantoni, L., & Garcia, J. H. (1997). Pathogenesis of leukoaraiosis, a review. Stroke, 28, 652-659.
23. Pantoni, L., Poggesi, A., Basile, A. M., Pracucci, G., Barkhof, F., Chabriat, H., et al. (2006). Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. Journal of the American Geriatrics Society, 54, 95-101.
24. Ravens, J. R. (1994). Anastomoses in the vascular bed of the human cerebrum. In J. Cervós-Navarro (Ed.), Pathology of Cerebral Microcirculation (pp. 26-28). Berlin, Germany: Walter de Gruyter.
25. Sawada, H., Udaka, F., Izumi, Y., Nishinaka, K., Kawakami, H., Nakamura, S., et al. (2000). Cerebral white matter lesions are not associated with ApoE genotype but with age and female sex in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 68, 653-666.
26. Schmidt, H., Fazekas, F., Kostner, G. M., van Duijn, C. M. C., & Schmidt, R. (2001). Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study. Stroke, 32, 405-412.
27. Schmidt, R., Schmidt, H., Fazekas, F., Kapeller, P., Roob, G., Lechner, A., et al. (2000). MRI cerebral white matter lesions and paraoxonase PON1 polymophism: three-year follow-up of the Austrian Stroke Prevention Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1811-1816.
28. Schmidt, R., Schmidt, H., Fazekas, F., Schumacher, M., Niederkorn, K., Kapeller, P., et al. (1997). Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke, 28, 951-956.
29. Steingart, A., Hachinski, V. C., Lau, C., Fox, A. J., Diaz, F., Cape, R., et al. (1987a). Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Archives of Neurology, 44, 32-35.
30. Steingart, A., Hachinski, V. C., Lau, C., Fox, A. J., Fox, H., Lee, D., et al. (1987b). Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Archives of Neurology, 44, 36-39.
31. Szolnoki, Z. (2007a). Chemical events behind leukoaraiosis: medicinal chemistry offers a new insight into a specific microcirculation disturbance in the brain (a chemical approach to a frequent cerebral phenotype). Current Medicinal Chemistry, 14, 1027-1236.
32. Szolnoki, Z. (2007b). Genetic variant-associated endothelial dysfunction behind small-vessel cerebral circulatory disorders: a new pathomechanism behind common cerebral phenotypes (Review). Mini Rev Med Chem, 7, 527-530.
33. Szolnoki, Z. (2007c). Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis). Neuromolecular Medicine, 9, 21-33.
34. Szolnoki, Z., Somogyvari, F., Kondacs, A., Szabo, M., & Fodor, L. (2001). Evaluation of the roles of common genetic mutations in leukoaraiosis. Acta Neurologica Scandinavica, 104, 281-287.
35. Szolnoki, Z., Somogyvari, F., Kondacs, A., Szabó, M., Fodor, L., Bene, J., et al. (2004). Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis. Acta Neurologica Scandinavica, 109, 222-227.
36. van Gijn, J. (1998). Leukoaraiosis and vascular dementia. Neurology, 51, 3-8.
37. Wardlaw, J. M., Sandercock, P. A. G., Dennis, M. S., & Starr, J. (2003). Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke, 34, 806-812.
38. World Health Organization, Group WS (1985). Diabetes mellitus. Report of WHO study group. WHO Tech Rep Ser, 6, 13-17.
39. Yao, H., Sadoshima, S., Ibayashi, S., Kuwabara, Y., Ichiya, Y., & Fujishima, M. (1992). Leukoaraiosis and dementia in hypertensive patients. Stroke, 23, 1673-1677.
40. Ylikoski, R., Ylikoski, A., Erkinjuntti, T., Sulkava, R., Raininko, R., & Tilvis, R. (1993). White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Archives of Neurology, 50, 818-824.